Mandate

Vinge acts as counsel to Orkla in connection with the acquisition of Health and Sports Nutrition Group

November 21, 2017 EU, Competition and Regulatory

Vinge acts as counsel to Orkla in connection with the acquisition of Health and Sports Nutrition Group HSNG AB (”HSNG”). The seller is Qliro Group AB (publ).

HSNG is a leading actor within e-commerce of health and sport nutrition in the Nordics and runs its business mainly through the internet stores Gymgrossisten.com and Bodystore.com. In addition, Gymgrossisten has physical franchise stores.

Orkla is a leading supplier of branded consumer goods and concept solutions to the grocery, out-of-home and bakery markets in the Nordics, Baltics and selected markets in Central Europe and India. Orkla is listed on the Oslo Stock Exchange and its head office is in Oslo. In 2016, the Group had a turnover of approximately NOK 38 billion, and 18,000 employees at year end.

The transaction is subject to the approval of the relevant competition authorities.

Vinge’s team consists, among others, of responsible partner Peter Sundgren as well as counsel Joacim Rydergård and associates Christina Odengran, Christoffer Nordin, Emelie Håkansson, Mika Jordan, Sara Strandberg, Filip Markhed and Ilze Lukins. Partner Johan Karlsson as well as, among others, associates Trine Osen Bergqvist and Xandra Ståhlberg are advising on competition law issues.

Related

Vinge advises Cinclus Pharma in connection with listing on Nasdaq Stockholm

Vinge advises Cinclus Pharma Holding AB (publ) (“Cinclus Pharma”) in connection with an offering of new ordinary shares and listing on Nasdaq Stockholm. The first day of trading is 20 June 2024.
June 20, 2024

Vinge advises Axcel VI and the Currentum in connection with the acquisition of Elektro-Emanuel

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elektro-Emanuel AB. The company carries out electrical installations for both companies and private individuals and has offices in four cities in western Sweden.
June 19, 2024

Vinge has advised the lead investor ARCH Venture Partners in Moleculent’s $26 million Series A financing

Moleculent AB, a company pioneering technology to study the communication between cells in human tissue, has closed its oversubscribed $26 million Series A financing. The round was led by ARCH Venture Partners and co-led by Eir Ventures with participation from the company’s existing investors.
June 19, 2024